The global functional electrical stimulation market is anticipated to be valued at US$ 620.9 million in 2023. The market is to register a CAGR of 4.1% and is estimated to reach US$ 931.4 million from 2023 to 2033.
Market Growth is attributed to the increasing prevalence of spinal cord injuries. From 2018 to 2022, a CAGR of 2.6% was registered for the functional electrical stimulation market.
The functional electrical stimulation industry is poised for significant growth, driven by a rising awareness of its therapeutic benefits and advancements in medical technology. FES involves using electrical impulses to stimulate nerves and muscles, enabling individuals with neurological or musculoskeletal disorders to regain functional mobility.
The prominent factors contributing to the optimistic outlook of the functional electrical stimulation business include an increasingly aging population, a high incidence of neurological disorders such as stroke, spinal cord injuries, and multiple sclerosis, and a growing demand for non-invasive and drug-free treatment options.
Functional electrical stimulation has shown promising results in improving muscle strength, reducing muscle atrophy, enhancing circulation, and restoring motor functions in such patients. Also, technological innovations are playing a pivotal role in expanding the functional electrical stimulation market.
Advancements in electrode design, wireless connectivity, and customizable programming have led to efficient and user-friendly FES devices. The collaborations between researchers, clinicians, and industry players foster the development of novel functional electrical stimulation applications. These applications include treating urinary incontinence, enhancing sports performance, and augmenting rehabilitation programs.
The market landscape is becoming increasingly competitive as established medical device companies and startups focus on product development and regulatory approvals. The challenges persist, including reimbursement issues and the need for long-term clinical evidence showcasing the sustained benefits of functional electrical stimulation interventions.
The functional electrical stimulation industry is on a positive trajectory, driven by the growing patient pool, technological advancements, and expanding therapeutic applications. As research continues to validate its efficacy and the regulatory environment becomes favorable, functional electrical stimulation can revolutionize the field of neurorehabilitation. It can also offer renewed hope to individuals striving to regain lost functional abilities.
Functional Electrical Stimulation Industry (From 2018 to 2022)
| CAGR | 2.6% |
|---|---|
| Market Size - 2018 | US$ 541.32 million |
| Market Size - 2022 | US$ 601.1 million |
Functional Electrical Stimulation Industry (From 2023 to 2033)
| CAGR | 4.1% |
|---|---|
| Market Size - 2023 | US$ 620.9 million |
| Market Size - 2033 | US$ 931.4 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Increasing Prevalence of Musculoskeletal Disorders to Increase Deployment of Functional Electric Stimulation
The functional electrical stimulation market is driven by various factors such as:
An unhealthy diet and lack of physical activities and exercise surge the functional electrical stimulation demand. Also, the prevalence of musculoskeletal disorders is rising globally due to unhealthy diets and lack of physical activity, which leads to obesity and musculoskeletal disorders.
According to WHO data from February 2021, around 1.71 billion people suffer from musculoskeletal conditions worldwide. Among these, low back pain causes a significant burden, with a prevalence of 568 million people suffering from the condition globally. The functional electrical stimulation demand may increase significantly with the increasing prevalence of musculoskeletal disorders.
Sustainability Challenges for the Functional Electrical Stimulation Manufacturers
Multiple obstacles are likely to challenge market growth although the functional electrical stimulation market has numerous end-uses. Long regulatory processes need to catch up on the launch of new items, slowing the market expansion. Market expansion is constrained by high implant costs, strict rules for product approvals, the need for skilled professionals, and the high cost of physiotherapy sessions.
Customers are enticed to choose alternative stimulation therapies such as yoga, acupuncture, and aromatherapy due to the high expense of electric stimulators. This may hinder the market growth for functional electrical stimulation. Further, the lack of usage guidelines, safety issues, and regulatory concerns restrict the market growth for functional electrical stimulation.
| Category | Product |
|---|---|
| Leading Segment | Wired |
| Market Share | 63.8% |
| Category | End User |
|---|---|
| Leading Segment | Hospitals |
| Market Share | 55.7% |
The wired functional electrical stimulation segment dominates in sales owing to its proven track record, dependability, and compatibility with existing medical systems. Furthermore, they are frequently used in therapeutic situations where precise control and reliable performance are required. Healthcare experts rely on their proven technology for focused muscle stimulation and rehabilitation.
Wired FES devices are viewed as cost-effective for long-term use, making them the favored choice for universities. Their familiarity and effortless incorporation into treatment protocols contribute to their dominating functional electrical stimulation sales position.
The hospital segment compels demand due to its complete care environment and broad patient base. Hospitals are a focal hub for many medical specializations, making functional electrical stimulation readily available to patients with varying needs.
The controlled hospital environment provides accurate FES administration and supervision, critical for safe and effective treatment. Hospital medical personnel is well-equipped to include functional electrical stimulation in broad patient care regimens, improving rehabilitation outcomes.
Functional electrical stimulation is an appealing alternative for various illnesses since hospitals frequently manage difficult situations. These reasons, taken together, present functional electrical stimulation in hospitals as the preferable option, contributing to functional electrical stimulation market growth.
Principal Consultant
| Region | Market Share - 2023 |
|---|---|
| North America | 40.0% |
| Europe | 28.1% |
Technological Advancement in Healthcare to Boost the Growth of the Market in North America
As per FMI, North America’s functional electrical stimulation industry is slated to account for 40.0% of the total market share. North America dominates the global functional electrical stimulation market, owning to regulatory support and increasing awareness among healthcare professionals.
The increasing incidence of chronic diseases, recent developments in FES devices, and the existence of the region's reputed medical device and MedTech companies boost the market growth for functional electrical stimulation.
Obesity is related to nervous system disorders and can lead to stroke, where the blood stops flowing to the brain. In America, obesity is rising due to changing lifestyles, such as having unhealthy diet choices and changing sleep schedules. For instance,
A Growing Healthcare System to Propel Growth of Functional Electric Stimulation
Europe is likely to capture a share of 28.1% in the functional electrical stimulation market by 2023. Increasing government expenditure in the healthcare sector is expected to boost sales in the forthcoming years. Further, the prevalence of musculoskeletal disorders is high in the region, which directly impacts the functional electrical stimulation market.
Growing government investments in the healthcare sector, increasing use of spinal cord stimulation devices in home healthcare settings, and rising acceptance of advanced medical device technologies by healthcare providers are the factors pushing the market expansion in the region.
| Region | Market CAGR (From 2023 to 2033) |
|---|---|
| Australia | 3.6% |
| China | 4.9% |
| India | 4.0% |
| The United Kingdom | 2.8% |
Growing Demand for High-Quality Treatment to Boost the Growth of the Functional Electric Stimulator Market
The functional electrical stimulation market in the Asia Pacific is projected to expand significantly during the forecast period. Growth in the Asia Pacific region can be primarily driven by increased patient awareness and acceptance of electric stimulation as an alternative treatment for chronic pain and neurological disorders.
China and India are expected to hold a large share of the functional electric stimulator market due to the high population density in this region. Further, an increase in demand for high-quality treatment, the popularity of electric stimulators, and technological advancements force the market in these regions. Also, the surge in healthcare expenditure and favorable reimbursement policies boost the market growth for functional electrical stimulation in the Asia Pacific.
| Region | Market Share (2023) |
|---|---|
| The United States | 39.7% |
| Germany | 6.2% |
| Japan | 4.2% |
Promoting a functional electrical stimulation (FES) product in the market requires a comprehensive marketing strategy that effectively communicates the benefits and features of the product to the target audience. Here are some marketing tactics that manufacturers can utilize to promote the functional electrical stimulation market:
| Attributes | Details |
|---|---|
| Educational Content Creation | Functional electrical stimulation manufacturers can create engaging instructional materials that describe the advantages, underpinnings, and applications of functional electrical stimulation. Ensure that they address the typical queries and worries that prospective clients could have regarding FES technology. Establish the company's reputation as an industry authority and trustworthy source of information. |
| Partnerships with Healthcare Professionals | Manufacturers can work with medical professionals, physical therapists, and institutions of higher learning to get endorsements and recommendations for the FES goods. The assistance of medical specialists can significantly impact purchasing choices in the healthcare industry. Provide the professionals with training sessions to ensure they can recommend and use your products. |
| Online Advertising and Social Media | The functional electrical stimulation manufacturers should put to use targeted web advertising strategies used to reach out to healthcare professionals, patients, and carers interested in FES technology. LinkedIn, Facebook, and Twitter are excellent channels for sharing success stories, instructional content, and community engagement. Visual content, such as movies and infographics, can aid in comprehending complicated subjects. |
| Demonstrations and Workshops | The functional electrical stimulation manufacturers should organize live demos and workshops to demonstrate the value of their FES products. Invite medical professionals, therapists, and potential consumers to try the gadget. Highlight real-world success stories and case studies to highlight FES's positive impact on rehabilitation and patient quality of life. |
| Trade Shows and Conferences | Participation in relevant industry trade fairs, conferences, and medical expos can showcase the manufacturers’ FES goods. These events allow a meeting with key stakeholders, networking with new customers, and remaining current on industry trends. The functional electrical stimulation manufacturers can also host their exhibit or presentation to enhance visibility. |
The functional electrical stimulation manufacturers should keep in mind that an effective marketing approach for FES goods should be adapted to the specific demands of the target consumers. Also, the manufacturers should focus on delivering value through education, showing efficacy, building relationships with professionals, and harnessing the power of online and offline channels to reach the targeted demographics.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The new entrants in the functional electrical stimulation market continually indulge in several collaborations and highly invest in research and development activities to provide convenient solutions to industry verticals. Some of the key startups leading the market's development are Fesia Technology, NeuCognic, Shenzhen XFT Medical Limited, Walnut Medical Pvt Ltd, and Orthotics Plus.
The functional electrical stimulation market is progressively fierce. Growing recognition of functional electrical stimulation applications in rehabilitation, neurology, and sports medicine contributes to market expansion.
The arrival of new competitors, technological developments and growing applications have increased competition in the functional electrical stimulation industry. In addition, established medical device businesses invest in FES research and development, resulting in novel products with enhanced functionality and user experience. Also, startups that are entirely focused on FES technology are developing and bringing fresh ideas and solutions to the market.
Incorporating wireless connectivity and smartphone apps for monitoring and controlling functional electrical stimulation equipment escalates the stakes. As a result, the functional electrical stimulation market is likely to expand, enabling competition as companies strive to acquire a significant share by addressing changing consumer wants and preferences.
Some of the key functional electrical stimulation manufacturers include HASOMED GmbH, Bioness Inc., Trulife, Otto Bock, Odstock Medical Limited, Hobbs Rehabilitation, MotoMed, Restorative Therapies, Medline Industries, G.tec Medical Engineering GmbH among others.
| Company | Bioventus Inc. |
|---|---|
| Strategy | Acquisition |
| Details | Bioventus Inc. announced the completion of its acquisition of CartiHeal in July 2022. |
| Company | Medline |
|---|---|
| Strategy | Partnership |
| Details | Medline increased its agreement with St. Johnland Nursing Center in July 2022, where the business might supply all capital equipment and furnishings for the organization's assisted living facility. |
| Company | Bioventus |
|---|---|
| Strategy | Acquisition |
| Details | Bioventus has acquired Bioness, a leader in neuromodulation and rehab devices, for US$ 45 million upfront and potentially US$ 65 million more based on milestones. Bioness products and employees are now part of Bioventus, aligning with its patient-focused growth strategy. |
The overall market might follow a y-o-y growth rate
of 4.1% through 2033.
The global market size is estimated to be around US$ 620.9 million.
Prevalence of musculoskeletal disorders is expanding
the demand for functional electrical stimulations.
The hospitals segment commanded nearly
55.7% of the global market in 2022.
China market is forecasted to expand at an impressive
3.9% CAGR through 2033.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Wired Devices
5.3.2. Wireless Devices
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Indication, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Indication, 2023 to 2033
6.3.1. for Neurological Disorders
6.3.2. for Pain Management
6.3.3. for Musculoskeletal Disorders
6.3.4. for Other Indications
6.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
7.3.1. in Hospitals
7.3.2. in Ambulatory Surgical Centers
7.3.3. in Clinics
7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Indication
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Indication
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Indication
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Indication
10.3.4. By End User
10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Product Type
11.2.3. By Indication
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Indication
11.3.4. By End User
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Product Type
12.2.3. By Indication
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Indication
12.3.4. By End User
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Product Type
13.2.3. By Indication
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Indication
13.3.4. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Product Type
14.2.3. By Indication
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Indication
14.3.4. By End User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product Type
15.2.3. By Indication
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Indication
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product Type
16.1.2.2. By Indication
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product Type
16.2.2.2. By Indication
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product Type
16.3.2.2. By Indication
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product Type
16.4.2.2. By Indication
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product Type
16.5.2.2. By Indication
16.5.2.3. By End User
16.6. UK
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product Type
16.6.2.2. By Indication
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product Type
16.7.2.2. By Indication
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product Type
16.8.2.2. By Indication
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product Type
16.9.2.2. By Indication
16.9.2.3. By End User
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product Type
16.10.2.2. By Indication
16.10.2.3. By End User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product Type
16.11.2.2. By Indication
16.11.2.3. By End User
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product Type
16.12.2.2. By Indication
16.12.2.3. By End User
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product Type
16.13.2.2. By Indication
16.13.2.3. By End User
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product Type
16.14.2.2. By Indication
16.14.2.3. By End User
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product Type
16.15.2.2. By Indication
16.15.2.3. By End User
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product Type
16.16.2.2. By Indication
16.16.2.3. By End User
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product Type
16.17.2.2. By Indication
16.17.2.3. By End User
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product Type
16.18.2.2. By Indication
16.18.2.3. By End User
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product Type
16.19.2.2. By Indication
16.19.2.3. By End User
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product Type
16.20.2.2. By Indication
16.20.2.3. By End User
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product Type
16.21.2.2. By Indication
16.21.2.3. By End User
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Product Type
16.22.2.2. By Indication
16.22.2.3. By End User
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Product Type
16.23.2.2. By Indication
16.23.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product Type
17.3.3. By Indication
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. HASOMED GmbH
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. Bioness Inc.
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. Trulife
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. Otto Bock
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. Odstock Medical Limited
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. Hobbs Rehabilitation
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. MotoMed
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. Restorative Therapies
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. Medline Industries
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
18.1.10. G.tec Medical Engineering GmbH
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.10.5.2. Product Strategy
18.1.10.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Functional Electrical Stimulation Market
